• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Genetic Modification of Bacteria to Rapidly Generate Economical Vaccines for Bacterial Infections

Allan Saul of the Novartis Vaccines Institute for Global Health in Italy will genetically modify gram-negative bacteria to generate large quantities of their outer membranes, which can be loaded with antigens that stimulate immune responses. This technology could prove to be a reliable and economic platform for generation of new vaccines.

More information about Create New Ways of Protecting Against Infectious Diseases (Round 1)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.